Fate Therapeutics, Inc.
NASDAQ:FATE
2.55 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 41.87 | 61.333 | 133.583 | 167.347 | 99.814 | 190.514 | 88.952 | 88.609 | 64.809 | 49.101 | 54.036 | 9.087 | 6.387 |
Short Term Investments
| 273.305 | 374.894 | 482.327 | 315.569 | 121.613 | 10.493 | 11.997 | 3.503 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 315.175 | 436.227 | 615.91 | 482.916 | 221.427 | 201.007 | 100.949 | 92.112 | 64.809 | 49.101 | 54.036 | 9.087 | 6.387 |
Net Receivables
| 2.726 | 38.48 | 8.676 | 5.515 | 1.338 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 13.639 | 27.367 | 8.826 | 5.892 | 4.324 | 3.689 | 1.647 | 1.211 | 0.843 | 0.771 | 0.615 | 0.706 | 0.301 |
Total Current Assets
| 331.54 | 502.074 | 633.412 | 494.323 | 227.089 | 205.196 | 102.596 | 93.323 | 65.652 | 49.872 | 54.651 | 9.793 | 6.688 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 158.511 | 66.069 | 70.72 | 67.084 | 22.752 | 5.125 | 2.55 | 1.579 | 2.16 | 1.2 | 0.81 | 1.161 | 1.042 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 16.157 | 4.942 | 100.664 | 28.733 | 39.44 | 2.185 | 0.122 | 0.122 | 0.122 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0.009 | 132.476 | 116.659 | 32.317 | 12.993 | 0.526 | 0.024 | 0.024 | 0.024 | 0.132 | 0.122 | 0.122 | 0.122 |
Total Non-Current Assets
| 174.677 | 203.487 | 288.043 | 128.134 | 75.185 | 7.836 | 2.696 | 1.725 | 2.306 | 1.332 | 0.932 | 1.283 | 1.164 |
Total Assets
| 506.217 | 705.561 | 921.455 | 622.457 | 302.274 | 213.032 | 105.292 | 95.048 | 67.958 | 51.204 | 55.583 | 11.076 | 7.852 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 4.719 | 8.265 | 8.612 | 6.283 | 5.822 | 4.205 | 1.678 | 0.934 | 0.996 | 0.645 | 0.682 | 2.519 | 2.06 |
Short Term Debt
| 6.176 | 5.628 | 5.577 | 3.355 | 1.692 | 2.438 | 7.254 | 8.187 | 7.55 | 1.546 | 1.732 | 1.941 | 1.248 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0.685 | 42.226 | 21.483 | 21.144 | 2.787 | 7.588 | 2.105 | 2.105 | 2.401 | 2.26 | 2.092 | 0.063 | 0.146 |
Other Current Liabilities
| 27.514 | 57.932 | 45.612 | 54.782 | 17.505 | 13.032 | 0.012 | 3.961 | 2.494 | 0.13 | 0.094 | 0.327 | 0.221 |
Total Current Liabilities
| 39.094 | 114.051 | 81.284 | 85.564 | 27.806 | 27.263 | 11.049 | 15.187 | 13.441 | 4.581 | 4.6 | 4.85 | 3.675 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 97.36 | 103.71 | 109.241 | 93.943 | 25.235 | 12.446 | 14.808 | 2.501 | 10.688 | 18.083 | 0 | 1.732 | 3.591 |
Deferred Revenue Non-Current
| 0 | 0 | 27.124 | 46.021 | 3.775 | 7.5 | 0.724 | 2.829 | 4.934 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 24.168 | 11.684 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 1.346 | 3.861 | 0.8 | 0.8 | 0.702 | 5.354 | 1.522 | 1.377 | 0.857 | 0.2 | 0.135 | 57.319 | 51.269 |
Total Non-Current Liabilities
| 98.706 | 107.571 | 161.333 | 152.448 | 29.712 | 25.3 | 17.054 | 6.707 | 16.479 | 18.283 | 0.135 | 59.051 | 54.86 |
Total Liabilities
| 137.8 | 221.622 | 242.617 | 238.012 | 57.518 | 52.563 | 28.103 | 21.894 | 29.92 | 22.864 | 4.735 | 63.901 | 58.535 |
Equity: | |||||||||||||
Preferred Stock
| 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0 | 0 | 56.526 | 0 |
Common Stock
| 0.099 | 0.097 | 0.096 | 0.088 | 0.076 | 0.065 | 0.053 | 0.041 | 0.029 | 0.021 | 0.02 | 0.001 | 0.001 |
Retained Earnings
| -1,211.732 | -1,050.804 | -769.083 | -556.932 | -383.545 | -285.396 | -218.798 | -175.846 | -142.384 | -112.392 | -86.509 | -65.615 | -51.376 |
Accumulated Other Comprehensive Income/Loss
| 0.015 | -1.854 | -0.762 | 0.07 | 0.022 | -0.002 | -0.003 | -0.001 | -3.472 | -2.787 | -2.296 | -1.749 | -1.16 |
Other Total Stockholders Equity
| 1,580.032 | 1,536.497 | 1,448.584 | 941.216 | 628.2 | 445.799 | 295.934 | 248.957 | 183.865 | 143.498 | 139.633 | -41.988 | 1.852 |
Total Shareholders Equity
| 368.417 | 483.939 | 678.838 | 384.445 | 244.756 | 160.469 | 77.189 | 73.154 | 38.038 | 28.34 | 50.848 | -52.825 | -50.683 |
Total Equity
| 368.417 | 483.939 | 678.838 | 384.445 | 244.756 | 160.469 | 77.189 | 73.154 | 38.038 | 28.34 | 50.848 | -52.825 | -50.683 |
Total Liabilities & Shareholders Equity
| 506.217 | 705.561 | 921.455 | 622.457 | 302.274 | 213.032 | 105.292 | 95.048 | 67.958 | 51.204 | 55.583 | 11.076 | 7.852 |